Vaccine to other Nations

क्षमा करें, यह समाचार आपके अनुरोध की भाषा में उपलब्ध नहीं है। कृपया यहाँ देखें।

A sub Group of the National Expert Group on Vaccine Administration for Corona virus was constituted to consider all matters related to vaccine export of corona virus vaccines and take necessary decisions with due regard to domestic production and ensuring adequate availability for the national vaccine programme for COVID. This Sub Group closely checks over the supplies.

External supplies of Made in India COVID  vaccines started 20.01.2021. Supplies have been undertaken in the form of “Grants in aid”, commercial sales by the manufacturers and through GAVI’s COVAX facility. GAVI’s COVAX facility has more than 190 members including India. Country-wise details for supply of vaccines till 17 March 2021 are enclosed. More than 7.47 crore vaccine doses have been supplied to Stats/UTs within the country so far. Once an epidemic takes form of a pandemic, its management has to be done keeping the entire globe as unit and in most circumstances, it is not possible to take either States-specific or country-specific approach. Hence, export of COVID vaccine which facilitates global action to vaccination is important to simultaneously protect the high-risk population in all the countries of the world, thereby breaking the chain of transmission and minimizing chances of import of COVID cases from foreign countries as well as neighbouring countries to India. Low/middle income Countries as well as nations with limited access to pharmaceutical technologies are at debilitating disadvantages in dealing with the pandemic. To this end, Govt. of India has allowed only limited export of vaccines while according highest priority to domestic needs.